Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05344040 · ClinicalTrials.gov registry record · Early Phase 1
Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial
A Early Phase 1 study, sponsored by Kessler Foundation.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT05344040: Completed Early Phase 1 study, sponsored by Kessler Foundation.
NCT05344040 is a Early Phase 1 study that has completed, run by Kessler Foundation. The registered enrollment target is 25 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05344040, a Early Phase 1 study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Cognitive processing speed (CPS) impairment is prevalent, impactful, and poorly-managed in multiple sclerosis (MS). Upwards of 67% of patients present with MS-related CPS impairment, which is associated with poor everyday life outcomes. There are no FDA-approved pharmacological treatments for CPS impairment in MS. This landscape creates a critical public health and clinical crisis that underscores the importance of identifying efficacious approaches for managing CPS impairment in MS. We believe that aerobic exercise training represents a promising and powerful behavioral approach. This project involves a single-blind randomized controlled trial of 16-weeks of remotely-delivered and supported aerobic walking exercise training compared with an active control condition (remotely-delivered and supported stretching and toning activities) on CPS (assessed remotely) in 24 fully-ambulatory, but CPS-impaired persons with MS. This pilot trial will be conducted in a fully-remote fashion, such that there are no required in-person visits to Kessler Foundation. Participants (N=24) will initially undertake baseline assessments of CPS remotely via a HIPAA-compliant virtual platform (i.e., Zoom for Healthcare). This assessment will also serve as a screen for ensuring impaired CPS. At this virtual study visit, participants further will undergo a neuropsychological test of verbal learning and complete questionnaires assessing physical activity and MS symptoms via computer (REDCap). Following baseline, participants will be randomly assigned into the remotely-delivered and supported aerobic walking exercise training intervention condition (n=12) or remotely-delivered and supported attention and social contact control condition (n=12) using concealment. Both conditions will be administered remotely over 16-weeks via telerehabilitation by a postdoctoral behavior coach during scheduled calls. Participants will undertake aerobic walking exercise training or stretching-and-toning in the hom
Primary Outcome
Cognitive processing speed will be measured using the Symbol Digit Modalities Test. The primary outcome measure is the total score.
Interventions
- BEHAVIORAL Remotely Delivered and Supported Aerobic Walking Exercise Training
- BEHAVIORAL Remotely Delivered and Supported Stretching and Toning Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2022-12-01 |
| Phase | Early Phase 1 |
What the finished NCT05344040 record still lists
NCT05344040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 2 interventions - of which Remotely Delivered and Supported Aerobic Walking Exercise Training is the first listed.
NCT05344040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05344040 about?
NCT05344040 is a clinical study titled "Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial". Cognitive processing speed (CPS) impairment is prevalent, impactful, and poorly-managed in multiple sclerosis (MS). Upwards of 67% of patients present with MS-related CPS impairment, which is associated with poor everyday life outcomes. There are no FDA-approved pharmacological treatments for CPS im...
What is the current status of trial NCT05344040?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2022-05-25. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT05344040?
The interventions under investigation include: Remotely Delivered and Supported Aerobic Walking Exercise Training (BEHAVIORAL), Remotely Delivered and Supported Stretching and Toning Exercise Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05344040?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05344040's enrollment target sits among peer trials
25 1000th of 2000 higher than 964 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI